Application Note: WB: 1:500. IHC-P: 1:50-1:100. IP: 1:200. ELISA: 1:50,000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Calculated MW: 52
Form: Liquid
Buffer (with preservative): Tris/Glycine pH 7.4-7.9, 30% glycerol, BSA, 0.02% sodium azide.
Concentration: 0.5 mg/ml (Please refer to the vial label for the specific concentration.)
Background: This gene encodes a seven-transmembrane G-protein-coupled receptor. The encoded protein responds to signaling through the neurotransmitter serotonin. The mRNA of this gene is subject to multiple RNA editing events, where adenosine residues encoded by the genome are converted to inosines. RNA editing is predicted to alter the structure of the second intracellular loop, thereby generating alternate protein forms with decreased ability to interact with G proteins. Abnormalities in RNA editing of this gene have been detected in victims of suicide that suffer from depression. In addition, naturally-occuring variation in the promoter and 5' non-coding and coding regions of this gene may show statistically-significant association with mental illness and behavioral disorders. Alternative splicing results in multiple different transcript variants. [provided by RefSeq, Jan 2015]
Uniprot ID: P28335
Antigen Species: Human
Immunogen: Synthetic peptide taken within amino acid region 400-458 on human 5-hydroxytryptamine receptor 2C.
Purification: Purified by antigen-affinity chromatography
Conjugation: Unconjugated
Full Name: 5-hydroxytryptamine receptor 2C
English
Deutsch
